false
--12-31
Q2
0001342958
http://fasb.org/us-gaap/2024#UsefulLifeTermOfLeaseMember
P69M
P1Y
P1Y
0001342958
2024-01-01
2024-06-30
0001342958
2024-08-15
0001342958
2024-06-30
0001342958
2023-12-31
0001342958
2024-04-01
2024-06-30
0001342958
2023-04-01
2023-06-30
0001342958
2023-01-01
2023-06-30
0001342958
us-gaap:ProductMember
2024-04-01
2024-06-30
0001342958
us-gaap:ProductMember
2023-04-01
2023-06-30
0001342958
us-gaap:ProductMember
2024-01-01
2024-06-30
0001342958
us-gaap:ProductMember
2023-01-01
2023-06-30
0001342958
us-gaap:ServiceOtherMember
2024-04-01
2024-06-30
0001342958
us-gaap:ServiceOtherMember
2023-04-01
2023-06-30
0001342958
us-gaap:ServiceOtherMember
2024-01-01
2024-06-30
0001342958
us-gaap:ServiceOtherMember
2023-01-01
2023-06-30
0001342958
us-gaap:CommonStockMember
2022-12-31
0001342958
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001342958
us-gaap:NoncontrollingInterestMember
2022-12-31
0001342958
us-gaap:RetainedEarningsMember
2022-12-31
0001342958
2022-12-31
0001342958
us-gaap:CommonStockMember
2023-03-31
0001342958
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001342958
us-gaap:NoncontrollingInterestMember
2023-03-31
0001342958
us-gaap:RetainedEarningsMember
2023-03-31
0001342958
2023-03-31
0001342958
us-gaap:CommonStockMember
2023-12-31
0001342958
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001342958
us-gaap:NoncontrollingInterestMember
2023-12-31
0001342958
us-gaap:RetainedEarningsMember
2023-12-31
0001342958
us-gaap:CommonStockMember
2024-03-31
0001342958
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001342958
us-gaap:NoncontrollingInterestMember
2024-03-31
0001342958
us-gaap:RetainedEarningsMember
2024-03-31
0001342958
2024-03-31
0001342958
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001342958
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001342958
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-03-31
0001342958
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001342958
2023-01-01
2023-03-31
0001342958
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001342958
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001342958
us-gaap:NoncontrollingInterestMember
2023-04-01
2023-06-30
0001342958
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001342958
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001342958
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001342958
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-03-31
0001342958
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001342958
2024-01-01
2024-03-31
0001342958
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001342958
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001342958
us-gaap:NoncontrollingInterestMember
2024-04-01
2024-06-30
0001342958
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001342958
us-gaap:CommonStockMember
2023-06-30
0001342958
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001342958
us-gaap:NoncontrollingInterestMember
2023-06-30
0001342958
us-gaap:RetainedEarningsMember
2023-06-30
0001342958
2023-06-30
0001342958
us-gaap:CommonStockMember
2024-06-30
0001342958
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001342958
us-gaap:NoncontrollingInterestMember
2024-06-30
0001342958
us-gaap:RetainedEarningsMember
2024-06-30
0001342958
DGLY:MergerAgreementMember
DGLY:PredecessorCommonStockMember
2022-08-23
0001342958
DGLY:MergerAgreementMember
DGLY:RegistrantCommonStockMember
2022-08-23
0001342958
2023-02-05
2023-02-06
0001342958
us-gaap:CommonClassAMember
DGLY:CloverLeafCapitalCorpMember
2023-06-30
0001342958
us-gaap:CommonClassAMember
DGLY:CloverLeafCapitalCorpMember
2023-06-01
2023-06-30
0001342958
us-gaap:CommonStockMember
DGLY:CloverLeafCapitalCorpMember
2023-06-30
0001342958
2023-01-01
2023-12-31
0001342958
us-gaap:DemandDepositsMember
2024-06-30
0001342958
us-gaap:DemandDepositsMember
2024-01-01
2024-06-30
0001342958
us-gaap:MoneyMarketFundsMember
2024-06-30
0001342958
us-gaap:MoneyMarketFundsMember
2024-01-01
2024-06-30
0001342958
us-gaap:DemandDepositsMember
2023-12-31
0001342958
us-gaap:DemandDepositsMember
2023-01-01
2023-12-31
0001342958
us-gaap:MoneyMarketFundsMember
2023-12-31
0001342958
us-gaap:MoneyMarketFundsMember
2023-01-01
2023-12-31
0001342958
DGLY:TwoThousandTwentySmallBusinessAdministrationNotesMember
2020-05-10
2020-05-12
0001342958
DGLY:TwoThousandTwentySmallBusinessAdministrationNotesMember
2020-05-12
0001342958
DGLY:TwoThousandTwentySmallBusinessAdministrationNotesMember
2024-06-30
0001342958
DGLY:TwoThousandTwentySmallBusinessAdministrationNotesMember
2024-04-01
2024-06-30
0001342958
DGLY:TwoThousandTwentySmallBusinessAdministrationNotesMember
2024-01-01
2024-06-30
0001342958
DGLY:JuneContingentNoteMember
2021-06-30
0001342958
DGLY:JuneContingentNoteMember
2021-06-27
2021-06-30
0001342958
DGLY:JuneContingentNoteMember
2024-06-30
0001342958
DGLY:JuneContingentNoteMember
2023-12-31
0001342958
DGLY:AugustContingentPaymentNoteMember
2021-08-31
0001342958
DGLY:AugustContingentPaymentNoteMember
2021-08-30
2021-08-31
0001342958
DGLY:AugustContingentPaymentNoteMember
2024-06-30
0001342958
DGLY:AugustContingentPaymentNoteMember
2023-12-31
0001342958
DGLY:TwentyTwentyThreeCommercialExtensionOfCreditMember
2023-02-23
0001342958
DGLY:TwentyTwentyThreeCommercialExtensionOfCreditMember
2023-02-23
2023-02-23
0001342958
DGLY:TwentyTwentyFourCommercialExtensionOfCreditMember
2024-01-22
0001342958
DGLY:TwentyTwentyFourCommercialExtensionOfCreditMember
2024-01-22
2024-01-22
0001342958
DGLY:TwentyTwentyFourCommercialExtensionOfCreditMember
2024-01-01
2024-06-30
0001342958
DGLY:SecuritiesPurchaseAgreementMember
2023-04-03
2023-04-05
0001342958
DGLY:SecuritiesPurchaseAgreementMember
2023-04-05
0001342958
us-gaap:WarrantMember
2023-04-05
0001342958
DGLY:WarrantOneMember
2023-04-05
0001342958
DGLY:WarrantTwoMember
2023-04-05
0001342958
DGLY:WarrantThreeMember
2023-04-05
0001342958
us-gaap:CommonStockMember
2023-04-03
2023-04-05
0001342958
DGLY:RegistrationRightsAgreementMember
2024-06-30
0001342958
2023-06-02
0001342958
us-gaap:CommonStockMember
2023-06-02
0001342958
us-gaap:CommonStockMember
2023-06-01
2023-06-02
0001342958
2023-06-01
2023-06-02
0001342958
DGLY:RevolvingLoanAgreementMember
2023-10-26
2023-10-26
0001342958
DGLY:RevolvingLoanAgreementMember
2023-10-26
0001342958
DGLY:RevolvingLoanAgreementMember
2024-04-01
2024-06-30
0001342958
DGLY:RevolvingLoanAgreementMember
2024-01-01
2024-06-30
0001342958
DGLY:MerchantCashAdvancesMember
2023-11-30
0001342958
DGLY:MerchantCashAdvancesMember
2023-11-29
2023-11-30
0001342958
DGLY:MerchantCashAdvancesMember
2024-01-01
2024-06-30
0001342958
DGLY:MerchantCashAdvancesEntertainmentSegmentMember
2024-03-31
0001342958
DGLY:MerchantCashAdvancesEntertainmentSegmentMember
2024-03-01
2024-03-31
0001342958
DGLY:MerchantCashAdvancesEntertainmentSegmentMember
2024-01-01
2024-06-30
0001342958
DGLY:MerchantCashAdvancesEntertainmentSegmentMember
2024-04-01
2024-06-30
0001342958
us-gaap:WarrantMember
2023-04-05
2023-04-05
0001342958
us-gaap:WarrantMember
srt:MinimumMember
2023-04-05
0001342958
us-gaap:WarrantMember
srt:MaximumMember
2023-04-05
0001342958
us-gaap:FairValueInputsLevel1Member
DGLY:WarrantLiabilityMember
2024-06-30
0001342958
us-gaap:FairValueInputsLevel2Member
DGLY:WarrantLiabilityMember
2024-06-30
0001342958
us-gaap:FairValueInputsLevel3Member
DGLY:WarrantLiabilityMember
2024-06-30
0001342958
DGLY:WarrantLiabilityMember
2024-06-30
0001342958
us-gaap:FairValueInputsLevel1Member
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2024-06-30
0001342958
us-gaap:FairValueInputsLevel2Member
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2024-06-30
0001342958
us-gaap:FairValueInputsLevel3Member
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2024-06-30
0001342958
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2024-06-30
0001342958
us-gaap:FairValueInputsLevel1Member
2024-06-30
0001342958
us-gaap:FairValueInputsLevel2Member
2024-06-30
0001342958
us-gaap:FairValueInputsLevel3Member
2024-06-30
0001342958
us-gaap:FairValueInputsLevel1Member
DGLY:WarrantLiabilityMember
2023-12-31
0001342958
us-gaap:FairValueInputsLevel2Member
DGLY:WarrantLiabilityMember
2023-12-31
0001342958
us-gaap:FairValueInputsLevel3Member
DGLY:WarrantLiabilityMember
2023-12-31
0001342958
DGLY:WarrantLiabilityMember
2023-12-31
0001342958
us-gaap:FairValueInputsLevel1Member
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2023-12-31
0001342958
us-gaap:FairValueInputsLevel2Member
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2023-12-31
0001342958
us-gaap:FairValueInputsLevel3Member
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2023-12-31
0001342958
DGLY:ContingentConsiderationPromissoryNotesAndContingentConsiderationEarnOutMember
2023-12-31
0001342958
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001342958
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001342958
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001342958
DGLY:ContingentConsiderationPromissoryNoteMember
2023-12-31
0001342958
DGLY:WarrantDerivativeLiabilitiesMember
2023-12-31
0001342958
DGLY:WarrantDerivativeLiabilitiesMember
2024-01-01
2024-06-30
0001342958
DGLY:ContingentConsiderationPromissoryNoteMember
2024-01-01
2024-06-30
0001342958
DGLY:ContingentConsiderationPromissoryNoteMember
2024-06-30
0001342958
DGLY:WarrantDerivativeLiabilitiesMember
2024-06-30
0001342958
us-gaap:BuildingMember
2024-06-30
0001342958
us-gaap:LandMember
2024-06-30
0001342958
us-gaap:FurnitureAndFixturesMember
srt:MinimumMember
2024-06-30
0001342958
us-gaap:FurnitureAndFixturesMember
srt:MaximumMember
2024-06-30
0001342958
srt:WarehouseMember
srt:MinimumMember
2024-06-30
0001342958
srt:WarehouseMember
srt:MaximumMember
2024-06-30
0001342958
DGLY:DemonstrationAndTradeshowEquipmentMember
srt:MinimumMember
2024-06-30
0001342958
DGLY:DemonstrationAndTradeshowEquipmentMember
srt:MaximumMember
2024-06-30
0001342958
us-gaap:BuildingImprovementsMember
srt:MinimumMember
2024-06-30
0001342958
us-gaap:BuildingImprovementsMember
srt:MaximumMember
2024-06-30
0001342958
DGLY:AircraftMember
2024-01-01
2024-06-30
0001342958
DGLY:OctoberTwoThousandTwentyThreeMember
2023-10-31
0001342958
DGLY:OctoberTwoThousandTwentyThreeMember
2023-10-01
2023-10-31
0001342958
DGLY:OctoberTwoThousandTwentyThreeMember
2024-06-30
0001342958
DGLY:WarehouseAndOfficeSpaceMember
srt:MinimumMember
2020-05-10
2020-05-13
0001342958
DGLY:WarehouseAndOfficeSpaceMember
srt:MaximumMember
2020-05-10
2020-05-13
0001342958
DGLY:WarehouseAndOfficeSpaceMember
2020-05-10
2020-05-13
0001342958
DGLY:WarehouseAndOfficeSpaceMember
2024-06-30
0001342958
srt:MinimumMember
DGLY:FirstMedicalBillingCompanyMember
2021-05-29
2021-06-30
0001342958
DGLY:FirstMedicalBillingCompanyMember
srt:MaximumMember
2021-05-29
2021-06-30
0001342958
DGLY:FirstMedicalBillingCompanyMember
2021-05-29
2021-06-30
0001342958
DGLY:FirstMedicalBillingCompanyMember
2024-06-30
0001342958
DGLY:SecondMedicalBillingCompanyMember
srt:MinimumMember
2021-08-29
2021-08-31
0001342958
DGLY:SecondMedicalBillingCompanyMember
srt:MaximumMember
2021-08-29
2021-08-31
0001342958
DGLY:SecondMedicalBillingCompanyMember
2021-08-29
2021-08-31
0001342958
DGLY:SecondMedicalBillingCompanyMember
2024-06-30
0001342958
srt:MinimumMember
DGLY:GoodyTicketsLLCAndTicketSmarterLLCMember
2021-09-01
2021-09-01
0001342958
srt:MaximumMember
DGLY:GoodyTicketsLLCAndTicketSmarterLLCMember
2021-09-01
2021-09-01
0001342958
DGLY:GoodyTicketsLLCAndTicketSmarterLLCMember
2021-09-01
2021-09-01
0001342958
DGLY:PrivateMedicalBillingCompanyMember
srt:MinimumMember
2021-12-30
2022-01-02
0001342958
DGLY:PrivateMedicalBillingCompanyMember
srt:MaximumMember
2021-12-30
2022-01-02
0001342958
DGLY:PrivateMedicalBillingCompanyMember
2021-12-30
2022-01-02
0001342958
DGLY:OfficeSpaceAndCopierMember
2024-04-01
2024-06-30
0001342958
DGLY:OfficeSpaceAndCopierMember
2024-01-01
2024-06-30
0001342958
DGLY:OfficeSpaceAndCopierMember
2024-06-30
0001342958
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2024-01-01
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:LicensesMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:LicensesMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:PatentsAndTrademarksMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:PatentsAndTrademarksMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:SEOContentMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:SEOContentMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:PersonalSeatLicensesMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:PersonalSeatLicensesMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:SoftwareMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:SoftwareMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:WebsiteEnhancementsEntertainmentSegmentMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:WebsiteEnhancementsEntertainmentSegmentMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:ClientAgreementsRevenueCycleManagementSegmentsMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
DGLY:ClientAgreementsRevenueCycleManagementSegmentsMember
2023-12-31
0001342958
DGLY:AmortizedIntangibleAssetsMember
2024-06-30
0001342958
DGLY:AmortizedIntangibleAssetsMember
2023-12-31
0001342958
DGLY:UnAmortizedIntangibleAssetsMember
us-gaap:GoodwillMember
2024-06-30
0001342958
DGLY:UnAmortizedIntangibleAssetsMember
us-gaap:GoodwillMember
2023-12-31
0001342958
DGLY:UnAmortizedIntangibleAssetsMember
DGLY:TradeNameMember
2024-06-30
0001342958
DGLY:UnAmortizedIntangibleAssetsMember
DGLY:TradeNameMember
2023-12-31
0001342958
DGLY:UnAmortizedIntangibleAssetsMember
DGLY:PatentsAndTrademarksPendingMember
2024-06-30
0001342958
DGLY:UnAmortizedIntangibleAssetsMember
DGLY:PatentsAndTrademarksPendingMember
2023-12-31
0001342958
2024-03-14
0001342958
DGLY:TwoThousandAndFivePlanMember
DGLY:DuringTwoThousandFifteenMember
2024-06-30
0001342958
DGLY:TwoThousandAndSixPlanMember
DGLY:DuringTwoThousandSixteenMember
2024-06-30
0001342958
DGLY:TwoThousandAndSevenPlanMember
DGLY:DuringTwoThousandSevenTeenMember
2024-06-30
0001342958
DGLY:TwoThousandAndSevenPlanMember
2024-06-30
0001342958
DGLY:TwoThousandAndEightPlanMember
DGLY:DuringTwoThousandEighteenMember
2024-06-30
0001342958
DGLY:TwoThousandAndEightPlanMember
2024-06-30
0001342958
us-gaap:RestrictedStockUnitsRSUMember
2024-06-30
0001342958
DGLY:StockOptionsMember
2023-12-31
0001342958
DGLY:StockOptionsMember
2024-01-01
2024-06-30
0001342958
DGLY:StockOptionsMember
2024-06-30
0001342958
DGLY:RangeOneMember
2024-01-01
2024-06-30
0001342958
DGLY:RangeOneMember
2024-06-30
0001342958
DGLY:RangeTwoMember
2024-01-01
2024-06-30
0001342958
DGLY:RangeTwoMember
2024-06-30
0001342958
DGLY:RangeThreeMember
2024-01-01
2024-06-30
0001342958
DGLY:RangeThreeMember
2024-06-30
0001342958
us-gaap:RestrictedStockMember
2023-12-31
0001342958
us-gaap:RestrictedStockMember
2024-01-01
2024-06-30
0001342958
us-gaap:RestrictedStockMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
2024-06-25
0001342958
us-gaap:WarrantMember
2024-06-30
0001342958
us-gaap:WarrantMember
2023-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExpectedDividendRateMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExpectedDividendRateMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExercisePriceMember
srt:MinimumMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExercisePriceMember
srt:MaximumMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExercisePriceMember
srt:MinimumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
us-gaap:MeasurementInputExercisePriceMember
srt:MaximumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
2023-04-05
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
srt:MinimumMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
srt:MaximumMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
srt:MinimumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
srt:MaximumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExpectedDividendRateMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExpectedDividendRateMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
srt:MinimumMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
srt:MaximumMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
srt:MinimumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
srt:MaximumMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExercisePriceMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
us-gaap:MeasurementInputExercisePriceMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
2024-06-25
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
2023-12-31
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
2024-01-01
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
DGLY:RangeOneMember
2024-01-01
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
DGLY:RangeOneMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
DGLY:RangeTwoMember
2024-01-01
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
DGLY:RangeTwoMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
DGLY:RangeThreeMember
2024-01-01
2024-06-30
0001342958
DGLY:TwoThousandTwentyThreePurchaseWarrantsMember
DGLY:RangeThreeMember
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
DGLY:RangeFourMember
2024-01-01
2024-06-30
0001342958
DGLY:TwoThousandTwentyFourPurchaseWarrantsMember
DGLY:RangeFourMember
2024-06-30
0001342958
DGLY:OfficersMember
2023-01-10
2023-01-10
0001342958
DGLY:NewEmployeesMember
2023-01-10
2023-01-10
0001342958
DGLY:NewEmployeesMember
srt:MinimumMember
2023-01-10
2023-01-10
0001342958
DGLY:NewEmployeesMember
srt:MaximumMember
2023-01-10
2023-01-10
0001342958
DGLY:OfficersMember
2024-01-01
2024-01-31
0001342958
DGLY:NewEmployeesMember
2024-01-01
2024-01-31
0001342958
DGLY:NewEmployeesMember
srt:MinimumMember
2024-01-01
2024-01-31
0001342958
DGLY:NewEmployeesMember
srt:MaximumMember
2024-01-01
2024-01-31
0001342958
DGLY:TheSecuritiesPurchaseAgreementMember
2024-06-24
2024-06-24
0001342958
us-gaap:PrivatePlacementMember
2024-06-24
2024-06-24
0001342958
us-gaap:PrivatePlacementMember
2024-06-24
0001342958
DGLY:NobilityHealthcareLLCMember
2024-06-30
0001342958
DGLY:NobilityHealthcareLLCMember
2024-06-30
0001342958
DGLY:NobilityHealthcareLLCMember
2024-04-01
2024-06-30
0001342958
DGLY:NobilityHealthcareLLCMember
2023-04-01
2023-06-30
0001342958
DGLY:NobilityHealthcareLLCMember
2024-01-01
2024-06-30
0001342958
DGLY:NobilityHealthcareLLCMember
2023-01-01
2023-06-30
0001342958
DGLY:CountryStampedeAcquisitionMember
2024-01-01
2024-06-30
0001342958
DGLY:JCEntertainmentLLCMember
2024-03-01
2024-03-01
0001342958
DGLY:CountryStampedeAcquisitionMember
2024-03-01
0001342958
DGLY:CountryStampedeAcquisitionMember
2024-03-01
2024-03-01
0001342958
DGLY:VideoSolutionsMember
2024-06-30
0001342958
DGLY:EntertainmentSegmentMember
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:VideoSolutionsMember
2024-04-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:VideoSolutionsMember
2023-04-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:VideoSolutionsMember
2024-01-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:VideoSolutionsMember
2023-01-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:RevenueCycleManagementMember
2024-04-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:RevenueCycleManagementMember
2023-04-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:RevenueCycleManagementMember
2024-01-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:RevenueCycleManagementMember
2023-01-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:EntertainmentSegmentMember
2024-04-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:EntertainmentSegmentMember
2023-04-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:EntertainmentSegmentMember
2024-01-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
DGLY:EntertainmentSegmentMember
2023-01-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
2024-04-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
2023-04-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
2024-01-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
2023-01-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
us-gaap:CorporateMember
2024-04-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
us-gaap:CorporateMember
2023-04-01
2023-06-30
0001342958
us-gaap:OperatingSegmentsMember
us-gaap:CorporateMember
2024-01-01
2024-06-30
0001342958
us-gaap:OperatingSegmentsMember
us-gaap:CorporateMember
2023-01-01
2023-06-30
0001342958
DGLY:VideoSolutionsMember
2023-12-31
0001342958
DGLY:RevenueCycleManagementMember
2024-06-30
0001342958
DGLY:RevenueCycleManagementMember
2023-12-31
0001342958
DGLY:EntertainmentSegmentMember
2023-12-31
0001342958
us-gaap:CorporateMember
2024-06-30
0001342958
us-gaap:CorporateMember
2023-12-31
0001342958
DGLY:NobilityLLCMember
2024-01-01
2024-06-30
0001342958
DGLY:NobilityLLCMember
2023-01-01
2023-06-30
0001342958
DGLY:NobilityLLCMember
DGLY:OperatingAgreementMember
2024-04-01
2024-06-30
0001342958
DGLY:NobilityLLCMember
DGLY:OperatingAgreementMember
2023-04-01
2023-06-30
0001342958
DGLY:NobilityLLCMember
DGLY:OperatingAgreementMember
2024-01-01
2024-06-30
0001342958
DGLY:NobilityLLCMember
DGLY:OperatingAgreementMember
2023-01-01
2023-06-30
0001342958
us-gaap:RelatedPartyMember
2023-09-22
0001342958
us-gaap:RelatedPartyMember
2023-10-02
0001342958
us-gaap:RelatedPartyMember
2024-06-30
0001342958
DGLY:NotePurchaseAgreementMember
2024-03-01
0001342958
DGLY:LetterAgreementMember
us-gaap:SubsequentEventMember
2024-07-13
0001342958
DGLY:LetterAgreementMember
srt:MaximumMember
us-gaap:SubsequentEventMember
2024-07-13
0001342958
DGLY:LetterAgreementMember
srt:MinimumMember
us-gaap:SubsequentEventMember
2024-07-13
0001342958
DGLY:LetterAgreementMember
us-gaap:SubsequentEventMember
2024-07-13
2024-07-13
0001342958
us-gaap:SubsequentEventMember
DGLY:PurchaseAndSaleAgreementMember
2024-08-02
2024-08-02
0001342958
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2024-08-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
DGLY:Segments
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For
the quarterly period ended June 30, 2024. |
or
☐ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For
the transition period from ___________ to __________. |
|
|
Commission
File Number: 001-33899 |
Digital
Ally, Inc.
(Exact
name of registrant as specified in its charter)
Nevada |
|
20-0064269 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(I.R.S.
Employer
Identification
No.) |
14001
Marshall Drive, Lenexa, KS 66215
(Address
of principal executive offices) (Zip Code)
(913)
814-7774
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of exchange on which registered |
Common
stock, $0.001 par value per share |
|
DGLY |
|
The
Nasdaq Capital Market LLC |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Yes
☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of Exchange Act.
Large
accelerated filer ☐ |
Accelerated
filer ☐ |
Non-accelerated
filer ☒ |
Smaller
reporting company ☒ |
Emerging
growth company ☐ |
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐ No ☒
Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
Class |
|
Outstanding
at August 15, 2024 |
Common
Stock, $0.001 par value per share |
|
3,855,160 |
FORM
10-Q
DIGITAL
ALLY, INC.
JUNE
30, 2024
PART
I – FINANCIAL INFORMATION
Item
1 – Financial Statements.
DIGITAL
ALLY, INC.
CONDENSED
CONSOLIDATED BALANCE SHEETS
| |
June 30, 2024 (Unaudited) | | |
December 31, 2023 | |
Assets | |
| | | |
| | |
Current assets: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 517,113 | | |
$ | 680,549 | |
Accounts receivable – trade, net of $239,391 allowance – June 30, 2024 and $200,668 – December 31, 2023 | |
| 1,343,205 | | |
| 1,584,662 | |
Other receivables, net of $25,000 allowance – June 30, 2024 and $5,000 – December 31, 2023 | |
| 3,545,833 | | |
| 3,107,634 | |
Inventories, net | |
| 2,218,133 | | |
| 3,845,281 | |
Prepaid expenses | |
| 6,620,477 | | |
| 6,366,368 | |
| |
| | | |
| | |
Total current assets | |
| 14,244,761 | | |
| 15,584,494 | |
| |
| | | |
| | |
Property, plant, and equipment, net | |
| 6,033,091 | | |
| 7,283,702 | |
Goodwill and other intangible assets, net | |
| 16,281,622 | | |
| 16,510,422 | |
Operating lease right of use assets, net | |
| 869,166 | | |
| 1,053,159 | |
Other assets | |
| 5,898,575 | | |
| 6,597,032 | |
| |
| | | |
| | |
Total assets | |
$ | 43,327,215 | | |
$ | 47,028,809 | |
| |
| | | |
| | |
Liabilities and Stockholders’ Equity | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 11,501,820 | | |
$ | 10,732,089 | |
Accrued expenses | |
| 3,380,005 | | |
| 3,269,330 | |
Current portion of operating lease obligations | |
| 223,629 | | |
| 279,538 | |
Contract liabilities – current portion | |
| 3,093,492 | | |
| 2,937,168 | |
Notes payable – related party – current portion | |
| 2,700,000 | | |
| 2,700,000 | |
Debt obligations – current portion | |
| 2,980,903 | | |
| 1,260,513 | |
Warrant derivative liabilities | |
| 3,796,748 | | |
| 1,369,738 | |
Income taxes payable | |
| — | | |
| 61 | |
| |
| | | |
| | |
Total current liabilities | |
| 27,676,597 | | |
| 22,548,437 | |
| |
| | | |
| | |
Long-term liabilities: | |
| | | |
| | |
Debt obligations – long term | |
| 4,898,418 | | |
| 4,853,237 | |
Operating lease obligation – long term | |
| 692,423 | | |
| 827,836 | |
Contract liabilities – long term | |
| 6,999,141 | | |
| 7,340,459 | |
Lease Deposit | |
| 10,445 | | |
| 10,445 | |
| |
| | | |
| | |
Total liabilities | |
| 40,277,024 | | |
| 35,580,414 | |
| |
| | | |
| | |
Commitments and contingencies | |
| - | | |
| - | |
| |
| | | |
| | |
Stockholders’ Equity: | |
| | | |
| | |
Common stock, $0.001 par value per share; 200,000,000 shares authorized; shares issued: 3,502,037 shares issued – June 30, 2024 and 2,800,754 shares issued – December 31, 2023 | |
| 3,502 | | |
| 2,801 | |
Additional paid in capital | |
| 128,995,997 | | |
| 128,441,083 | |
Noncontrolling interest in consolidated subsidiary | |
| 734,354 | | |
| 673,292 | |
Accumulated deficit | |
| (126,683,662 | ) | |
| (117,668,781 | ) |
| |
| | | |
| | |
Total stockholders’ equity | |
| 3,050,191 | | |
| 11,448,395 | |
| |
| | | |
| | |
Total liabilities and stockholders’ equity | |
$ | 43,327,215 | | |
$ | 47,028,809 | |
See
Notes to the Unaudited Condensed Consolidated Financial Statements.
DIGITAL
ALLY, INC.
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
For the three months ended June 30, | | |
For the six months ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Revenue: | |
| | | |
| | | |
| | | |
| | |
Product | |
$ | 2,207,601 | | |
$ | 3,077,661 | | |
$ | 3,773,447 | | |
$ | 5,531,469 | |
Service and other | |
| 3,408,634 | | |
| 5,201,971 | | |
| 7,372,139 | | |
| 10,445,351 | |
| |
| | | |
| | | |
| | | |
| | |
Total revenue | |
| 5,616,235 | | |
| 8,279,632 | | |
| 11,145,586 | | |
| 15,976,820 | |
| |
| | | |
| | | |
| | | |
| | |
Cost of revenue: | |
| | | |
| | | |
| | | |
| | |
Product | |
| 3,419,254 | | |
| 2,219,515 | | |
| 4,986,647 | | |
| 4,520,616 | |
Service and other | |
| 1,954,589 | | |
| 3,323,077 | | |
| 4,395,109 | | |
| 7,174,375 | |
| |
| | | |
| | | |
| | | |
| | |
Total cost of revenue | |
| 5,373,843 | | |
| 5,542,592 | | |
| 9,381,756 | | |
| 11,694,991 | |
| |
| | | |
| | | |
| | | |
| | |
Gross profit | |
| 242,392 | | |
| 2,737,040 | | |
| 1,763,830 | | |
| 4,281,829 | |
| |
| | | |
| | | |
| | | |
| | |
Selling, general and administrative expenses: | |
| | | |
| | | |
| | | |
| | |
Research and development expense | |
| 545,776 | | |
| 540,276 | | |
| 1,033,242 | | |
| 1,475,215 | |
Selling, advertising and promotional expense | |
| 728,906 | | |
| 2,104,625 | | |
| 1,487,762 | | |
| 3,952,115 | |
General and administrative expense | |
| 2,881,931 | | |
| 5,032,843 | | |
| 6,796,019 | | |
| 9,968,010 | |
| |
| | | |
| | | |
| | | |
| | |
Total selling, general and administrative expenses | |
| 4,156,613 | | |
| 7,677,744 | | |
| 9,317,023 | | |
| 15,395,340 | |
| |
| | | |
| | | |
| | | |
| | |
Operating loss | |
| (3,914,221 | ) | |
| (4,940,704 | ) | |
| (7,553,193 | ) | |
| (11,113,511 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income (expense): | |
| | | |
| | | |
| | | |
| | |
Interest income | |
| 29,933 | | |
| 55,730 | | |
| 49,289 | | |
| 71,085 | |
Interest expense | |
| (1,085,063 | ) | |
| (1,515,509 | ) | |
| (1,733,690 | ) | |
| (1,521,049 | ) |
Other income | |
| 30,445 | | |
| 25,394 | | |
| 58,046 | | |
| 50,786 | |
Loss on accrual for legal settlement | |
| — | | |
| (1,792,308 | ) | |
| — | | |
| (1,792,308 | ) |
Loss on conversion of convertible note | |
| — | | |
| (93,386 | ) | |
| — | | |
| (93,386 | ) |
Change in fair value of warrant derivative liabilities | |
| (2,818 | ) | |
| (59,766 | ) | |
| (351,710 | ) | |
| (59,766 | ) |
Change in fair value of contingent consideration promissory notes | |
| — | | |
| — | | |
| — | | |
| 158,021 | |
Gain on extinguishment of liabilities | |
| — | | |
| — | | |
| 682,345 | | |
| — | |
Loss on extinguishment of debt | |
| (68,827 | ) | |
| | | |
| (68,827 | ) | |
| | |
Gain on sale of intangibles | |
| — | | |
| — | | |
| 5,582 | | |
| — | |
Loss on sale of property, plant and equipment | |
| — | | |
| — | | |
| (41,661 | ) | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Total other income (expense) | |
| (1,096,330 | ) | |
| (3,379,845 | ) | |
| (1,400,626 | ) | |
| (3,186,617 | ) |
| |
| | | |
| | | |
| | | |
| | |
Income tax benefit | |
| — | | |
| — | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
| (5,010,551 | ) | |
| (8,320,549 | ) | |
| (8,953,819 | ) | |
| (14,300,128 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net (income) attributable to noncontrolling interests of consolidated subsidiary | |
| (73,310 | ) | |
| (72,755 | ) | |
| (61,063 | ) | |
| (198,994 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss attributable to common stockholders | |
$ | (5,083,861 | ) | |
$ | (8,393,304 | ) | |
$ | (9,014,882 | ) | |
$ | (14,499,122 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss per share information: | |
| | | |
| | | |
| | | |
| | |
Basic | |
$ | (1.74 | ) | |
$ | (3.01 | ) | |
$ | (3.12 | ) | |
$ | (5.24 | ) |
Diluted | |
$ | (1.74 | ) | |
$ | (3.01 | ) | |
$ | (3.12 | ) | |
$ | (5.24 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average shares outstanding: | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 2,921,307 | | |
| 2,785,663 | | |
| 2,891,205 | | |
| 2,768,683 | |
Diluted | |
| 2,921,307 | | |
| 2,785,663 | | |
| 2,891,205 | | |
| 2,768,683 | |
See
Notes to the Unaudited Condensed Consolidated Financial Statements.
DIGITAL
ALLY, INC.
CONDENSED
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
| |
Shares | | |
Amount | | |
Capital | | |
subsidiary | | |
deficit | | |
Total | |
| |
Common Stock | | |
Additional Paid In | | |
Noncontrolling interest in consolidated | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
Capital | | |
subsidiary | | |
deficit | | |
Total | |
Balance, December 31, 2022 | |
| 2,720,170 | | |
$ | 2,721 | | |
$ | 127,869,342 | | |
$ | 448,694 | | |
$ | (91,980,234 | ) | |
$ | 36,340,523 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| — | | |
| — | | |
| 114,848 | | |
| — | | |
| — | | |
| 114,848 | |
Restricted common stock forfeitures | |
| 35,000 | | |
| 35 | | |
| (35 | ) | |
| — | | |
| — | | |
| — | |
Issuance due to rounding from reverse stock split | |
| 54 | | |
| — | | |
| — | | |
| | | |
| — | | |
| — | |
Net income (loss) | |
| — | | |
| — | | |
| — | | |
| 126,239 | | |
| (6,105,818 | ) | |
| (5,979,579 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, March 31, 2023 | |
| 2,755,224 | | |
$ | 2,756 | | |
$ | 127,984,155 | | |
$ | 574,933 | | |
$ | (98,086,052 | ) | |
$ | 30,475,792 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| — | | |
| — | | |
| 179,483 | | |
| — | | |
| — | | |
| 179,483 | |
Restricted common stock forfeitures | |
| (3,625 | ) | |
| (4 | ) | |
| 4 | | |
| — | | |
| — | | |
| — | |
Issuance due to rounding from reverse stock split | |
| 24,154 | | |
| 24 | | |
| (24 | ) | |
| — | | |
| — | | |
| — | |
Conversion of convertible note into common stock | |
| 25,000 | | |
| 25 | | |
| 119,725 | | |
| — | | |
| — | | |
| 119,750 | |
Net income (loss) | |
| — | | |
| — | | |
| — | | |
| 72,755 | | |
| (8,393,304 | ) | |
| (8,320,549 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, June 30, 2023 | |
| 2,800,753 | | |
$ | 2,801 | | |
$ | 128,283,343 | | |
$ | 647,688 | | |
$ | (106,479,356 | ) | |
$ | 22,454,476 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, December 31, 2023 | |
| 2,800,754 | | |
$ | 2,801 | | |
$ | 128,441,083 | | |
$ | 673,292 | | |
$ | (117,668,781 | ) | |
$ | 11,448,395 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| — | | |
| — | | |
| 40,695 | | |
| — | | |
| — | | |
| 40,695 | |
Restricted common stock grant | |
| 80,197 | | |
| 80 | | |
| (80 | ) | |
| — | | |
| — | | |
| — | |
Restricted common stock forfeitures | |
| (1,125 | ) | |
| (1 | ) | |
| 1 | | |
| — | | |
| — | | |
| — | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (12,248 | ) | |
| (3,931,020 | ) | |
| (3,943,268 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, March 31, 2024 | |
| 2,879,826 | | |
$ | 2,880 | | |
$ | 128,481,699 | | |
$ | 661,044 | | |
$ | (121,599,801 | ) | |
$ | 7,545,822 | |
Balance | |
| 2,879,826 | | |
$ | 2,880 | | |
$ | 128,481,699 | | |
$ | 661,044 | | |
$ | (121,599,801 | ) | |
$ | 7,545,822 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| — | | |
| — | | |
| 60,772 | | |
| — | | |
| — | | |
| 60,772 | |
Sale of common stock and pre-funded warrants, net of offering costs | |
| 622,211 | | |
| 622 | | |
| 2,528,826 | | |
| — | | |
| — | | |
| 2,529,448 | |
Fair value of warrants issued along with sale of common stock | |
| — | | |
| — | | |
| (2,075,300 | ) | |
| — | | |
| — | | |
| (2,075,300 | ) |
Net Income (loss) | |
| — | | |
| — | | |
| — | | |
| 73,310 | | |
| (5,083,861 | ) | |
| (5,010,551 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, June 30, 2024 | |
| 3,502,037 | | |
$ | 3,502 | | |
$ | 128,995,997 | | |
$ | 734,354 | | |
$ | (126,683,662 | ) | |
$ | 3,050,191 | |
Balance | |
| 3,502,037 | | |
$ | 3,502 | | |
$ | 128,995,997 | | |
$ | 734,354 | | |
$ | (126,683,662 | ) | |
$ | 3,050,191 | |
See
Notes to the Unaudited Condensed Consolidated Financial Statements.
DIGITAL
ALLY, INC.
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR
THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023
(Unaudited)
| |
2024 | | |
2023 | |
| |
For the six months ended June 30, | |
| |
2024 | | |
2023 | |
Cash Flows From Operating Activities: | |
| | | |
| | |
Net loss | |
$ | (8,953,819 | ) | |
$ | (14,300,128 | ) |
Adjustments to reconcile net loss to net cash flows used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 1,079,000 | | |
| 1,091,042 | |
Loss on accrual for legal settlement | |
| — | | |
| 1,792,308 | |
Loss on sale of property, plant and equipment | |
| 41,661 | | |
| — | |
Gain on sale on intangible | |
| (5,582 | ) | |
| — | |
Stock-based compensation | |
| 101,467 | | |
| 294,331 | |
Non-cash interest expense | |
| 150,000 | | |
| 576,380 | |
Amortization of debt issuance costs | |
| 1,105,168 | | |
| — | |
Gain on extinguishment of liabilities | |
| (682,345 | ) | |
| — | |
Loss on extinguishment of debt | |
| 68,827 | | |
| — | |
Change in fair value of warrant derivative liabilities | |
| 351,710 | | |
| 59,766 | |
Convertible debt discount amortization | |
| — | | |
| 925,455 | |
Loss on conversion of debt | |
| — | | |
| 93,386 | |
Provision for inventory obsolescence | |
| (407,460 | ) | |
| (75,007 | ) |
Provision for doubtful accounts receivable | |
| 38,724 | | |
| 24,140 | |
Allowance for doubtful lease reserve | |
| 20,000 | | |
| 5,000 | |
Change in fair value of contingent consideration promissory note | |
| — | | |
| (158,021 | ) |
| |
| | | |
| | |
Change in operating assets and liabilities: | |
| | | |
| | |
(Increase) decrease in: | |
| | | |
| | |
Accounts receivable – trade | |
| (284,767 | ) | |
| 155,015 | |
Other receivable | |
| (458,199 | ) | |
| 1,318,442 | |
Inventories | |
| 2,075,608 | | |
| 1,074,197 | |
Prepaid expenses | |
| (235,109 | ) | |
| 1,503,919 | |
Operating lease right of use assets | |
| 110,099 | | |
| 195,894 | |
Other assets | |
| 698,456 | | |
| (2,092,524 | ) |
Increase (decrease) in: | |
| | | |
| | |
Accounts payable | |
| 2,307,612 | | |
| 3,066,137 | |
Accrued expenses | |
| (128,075 | ) | |
| 56,606 | |
Accrued Expenses – related party | |
| 188,750 | | |
| — | |
Income taxes payable | |
| (61 | ) | |
| (17,444 | ) |
Lease deposit | |
| — | | |
| 10,445 | |
Operating lease obligations | |
| (117,428 | ) | |
| (195,894 | ) |
Contract liabilities | |
| (472,994 | ) | |
| 1,486,569 | |
| |
| | | |
| | |
Net cash used in operating activities | |
| (3,408,757 | ) | |
| (3,109,986 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Purchases of property, plant and equipment | |
| (24,882 | ) | |
| (52,338 | ) |
Additions to intangible assets | |
| (65,361 | ) | |
| (74,608 | ) |
Cash paid for acquisition of Country Stampede | |
| (514,432 | ) | |
| — | |
Proceeds from sale of intangible asset | |
| 90,535 | | |
| — | |
Proceeds from sale of property, plant and equipment | |
| 550,644 | | |
| — | |
| |
| | | |
| | |
Net cash provided by (used in) investing activities | |
| 36,504 | | |
| (126,946 | ) |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Proceeds – Merchant Advances – Video Solutions Segment | |
| 1,144,000 | | |
| — | |
Proceeds – Merchant Advances – Entertainment Segment | |
| 915,000 | | |
| — | |
Net proceeds of equity offering with detachable warrants | |
| 2,194,742 | | |
| — | |
Net proceeds of convertible debt with detachable warrants | |
| — | | |
| 2,640,000 | |
Proceeds – Commercial Extension of Credit – Entertainment Segment | |
| 575,000 | | |
| 1,000,000 | |
Payments on Commercial Extension of Credit – Entertainment Segment | |
| (162,928 | ) | |
| (794,332 | ) |
Payments on Merchant Advances – Video Solutions Segment | |
| (1,215,000 | ) | |
| — | |
Payments on Merchant Advances – Entertainment Segment | |
| (51,899 | ) | |
| — | |
Principal payment on EIDL loan | |
| (1,628 | ) | |
| — | |
Principal payment on contingent consideration promissory notes | |
| (188,470 | ) | |
| (217,054 | ) |
| |
| | | |
| | |
Net cash provided by financing activities | |
| 3,208,817 | | |
| 2,628,614 | |
| |
| | | |
| | |
Net decrease in cash, cash equivalents, and restricted cash | |
| (163,436 | ) | |
| (608,318 | ) |
| |
| | | |
| | |
Cash, cash equivalents and restricted cash, beginning of period | |
| 778,149 | | |
| 3,532,199 | |
| |
| | | |
| | |
Cash, cash equivalents and restricted cash, end of period | |
$ | 614,713 | | |
$ | 2,923,881 | |
| |
| | | |
| | |
Supplemental disclosures of cash flow information: | |
| | | |
| | |
Cash payments for interest | |
$ | 293,441 | | |
$ | 18,129 | |
| |
| | | |
| | |
Cash payments for income taxes | |
$ | 8,097 | | |
$ | 8,097 | |
| |
| | | |
| | |
Supplemental disclosures of non-cash investing and financing activities: | |
| | | |
| | |
Commercial extension of credit repaid through accrued revenue – Entertainment segment | |
$ | 487,500 | | |
$ | 30,052 | |
| |
| | | |
| | |
ROU and lease liability recorded on extension (termination) of lease | |
$ | (73,894 | ) | |
$ | 538,056 | |
| |
| | | |
| | |
Conversion of convertible notes payable into common stock | |
$ | — | | |
$ | 119,750 | |
| |
| | | |
| | |
Fair value of warrants issued with sale of shares | |
$ | 2,075,300 | | |
$ | — | |
| |
| | | |
| | |
Assets acquired in business acquisitions | |
$ | 605,000 | | |
$ | — | |
| |
| | | |
| | |
Liabilities assumed in the business acquisition | |
$ | 288,000 | | |
$ | — | |
| |
| | | |
| | |
Goodwill acquired in business acquisitions | |
$ | 225,959 | | |
$ | — | |
| |
| | | |
| | |
Adjustments of accounts payable with the sale proceeds of property, plant and equipment | |
$ | 549,356 | | |
$ | — | |
| |
| | | |
| | |
Restricted common stock grant | |
$ | 80 | | |
$ | 35 | |
| |
| | | |
| | |
Reverse stock split rounding issuances | |
$ | — | | |
$ | 24 | |
| |
| | | |
| | |
Restricted common stock forfeitures | |
$ | 1 | | |
$ | 4 | |
| |
| | | |
| | |
Debt discount on convertible note | |
$ | — | | |
$ | 3,000,000 | |
See
Notes to the Unaudited Condensed Consolidated Financial Statements.
DIGITAL
ALLY, INC.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE
1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature
of Operations:
Digital
Ally, Inc. was originally incorporated in Nevada on December 13, 2000 as Vegas Petra, Inc. and had no operations until 2004. On November
30, 2004, Vegas Petra, Inc. entered into a Plan of Merger with Digital Ally, Inc., at which time the merged entity was renamed Digital
Ally, Inc. (such merged entity, the “Predecessor Registrant”).
On
August 23, 2022 (the “Effective Time”), the Predecessor Registrant merged with and into its wholly owned subsidiary,
DGLY Subsidiary Inc., a Nevada corporation (the “Registrant”), pursuant to an agreement and plan of merger, dated
as of August 23, 2022 (the “Merger Agreement”), between the Predecessor Registrant and the Registrant, with the Registrant
as the surviving corporation in the merger (such transaction, the “Merger”). At the Effective Time, Articles of Merger
were filed with the Secretary of State of the State of Nevada, pursuant to which the Registrant was renamed “Digital Ally, Inc.”
and, by operation of law, succeeded to the assets, continued the business and assumed the rights and obligations of the Predecessor Registrant
immediately prior to the Merger. Under the Nevada Revised Statutes, shareholder approval was not required in connection with the Merger
Agreement or the transactions contemplated thereby.
At
the Effective Time, pursuant to the Merger Agreement, (i) each outstanding share of Predecessor Registrant’s common stock, par
value $0.001 per share (the “Predecessor Common Stock”) automatically converted into one share of common stock, par
value $0.001 per share, of the Registrant (“Registrant Common Stock”), (ii) each outstanding option, right or warrant
to acquire shares of Predecessor Common Stock converted into an option, right or warrant, as applicable, to acquire an equal number of
shares of Registrant Common Stock under the same terms and conditions as the original options, rights or warrants, and (iii) the directors
and executive officers of the Predecessor Registrant were appointed as directors and executive officers, as applicable, of the Registrant,
each to serve in the same capacity and for the same term as such person served with the Predecessor Registrant immediately before the
Merger.
The
business of the Registrant, Digital Ally, Inc. (with its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products,
LLC, Digital Ally Healthcare, LLC (“Digital Ally Healthcare”), TicketSmarter, Inc. (“TicketSmarter”), Worldwide
Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc. (“Kustom 440”), Kustom Entertainment, Inc.,
and its majority-owned subsidiary Nobility Healthcare, LLC, collectively, “Digital Ally,” “Digital,” and the
“Company”), is divided into three reportable operating segments: 1) the Video Solutions Segment, 2) the Revenue Cycle Management
Segment and 3) the Ticketing Segment. The Video Solutions Segment is our legacy business that produces digital video imaging, storage
products, disinfectant and related safety products for use in law enforcement, security and commercial applications. This segment includes
both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video
and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare
organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers
and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell
through various platforms. The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating
segments in annual financial statements and requires selected information of those segments to be presented in financial statements.
Such required segment information is included in Note 18.
Reverse
Stock Split
On
February 6, 2023, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State
of the State of Nevada to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the shares of its common stock.
The Reverse Stock Split was effective as of time of filing. No fractional shares were issued in connection with the Reverse Stock Split.
Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest
whole number. In connection with the Reverse Stock Split, the board of directors of the Company approved appropriate and proportional
adjustments to all outstanding securities or other rights convertible or exercisable into shares of the Company’s common stock,
including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and
per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this
Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value
per share of the Company’s common stock was not affected by the Reverse Stock Split.
Business
Combination
In
June 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Clover Leaf Capital Corp.,
a Delaware corporation (Nasdaq: CLOE) (“Clover Leaf”), CL Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary
of Clover Leaf (“Merger Sub”), Yntegra Capital Investments LLC, a Delaware limited liability company, in the capacity as
the representative from and after the Effective Time (as defined in the Merger Agreement) for the stockholders of Clover Leaf in accordance
with the terms and conditions of the Merger Agreement, and Kustom Entertainment, Inc., a Nevada corporation, a wholly owned subsidiary
of the Company, with a focus and mission to own and produce events, festivals, and entertainment alongside its evolving primary and secondary
ticketing technologies (“Kustom”). Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein
upon the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub will merge with
and into Kustom (the “Merger”), with Kustom continuing as the surviving corporation in the Merger and a wholly owned subsidiary
of Clover Leaf. In the Merger, all of the issued and outstanding capital stock of Kustom immediately prior to the Closing shall no longer
be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right for the Company to receive the
Merger Consideration (as defined below).
The
total consideration to be received by Company and its financial advisor at the Closing in connection with the Merger (the “Merger
Consideration”) will be a number of newly issued shares of Class A Common Stock, par value $0.0001 per share, of Clover Leaf (the
“Combined Company Common Stock”) with an aggregate value equal to $125,000,000, subject to adjustments for Kustom’s
closing debt (net of cash) and based on a deemed value of $11.14 per share of Combined Company Common Stock.
The
Company will also distribute to its stockholders and certain of its warrant holders 30% of the Combined Company Common Stock received
as Merger Consideration immediately following the Closing, and will distribute the balance of such shares immediately following the lock-up period,
which will expire six months after the Closing.
The
Closing is subject to the approval of Clover Leaf’s shareholders and the satisfaction or waiver of certain other customary closing
conditions.
Basis
of Presentation:
The
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly,
they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete
financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for
a fair presentation have been included. Operating results for the three- and six-month period ended June 30, 2024 are not necessarily
indicative of the results that may be expected for the year ending December 31, 2024.
The
balance sheet at December 31, 2023 has been derived from the audited financial statements at that date, but does not include all the
information and footnotes required by generally accepted accounting principles in the United States for complete financial statements.
For
further information, refer to the audited financial statements and footnotes included in the Company’s annual report on Form 10-K
for the year ended December 31, 2023.
Liquidity
and Going Concern
During
the second quarter of 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40):
Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This update provided U.S. GAAP guidance on
management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going
concern and about related footnote disclosures. Under this standard, the Company is required to evaluate whether there is substantial
doubt about its ability to continue as a going concern each reporting period, including interim periods. In evaluating the Company’s
ability to continue as a going concern, management considered the conditions and events that could raise substantial doubt about the
Company’s ability to continue as a going concern within 12 months after the Company’s financial statements were issued (August
15, 2024). Management considered the Company’s current financial condition and liquidity sources, including current funds available,
forecasted future cash flows and the Company’s obligations due before August 15, 2024.
The
Company has experienced net losses and cash outflows from operating activities since inception. For the six months ended June 30, 2024,
the Company had a net loss attributable to common stockholders of $8,953,819, net cash used in operating activities of $3,408,757, $36,504
provided by investing activities and $3,208,817 provided by financing activities. The Company will have to restore positive operating
cash flows and profitability over the next year and/or raise additional capital to fund its operational plans, meet its customary payment
obligations and otherwise execute its business plan. There can be no assurance that it will be successful in restoring positive cash
flows and profitability, or that it can raise additional financing when needed, and obtain it on terms acceptable or favorable to the
Company.
The
Company has implemented an enhanced quality control program to detect and correct product issues before they result in significant rework
expenditures affecting its gross margins and has seen progress in that regard. The Company has also implemented a marketing and advertisement
reduction plan for its entertainment segment, which will focus on reducing and alleviating current obligations from its media marketing
agreements and place a hold on entering into any new agreements. The Company believes that its quality control, cost-cutting initiatives,
and new product introduction will eventually restore positive operating cash flows and profitability, although it can offer no assurances
in this regard.
Management
has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and
concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the
date the unaudited condensed consolidated financial statements were issued.
Basis
of Consolidation:
The
accompanying financial statements include the consolidated accounts of Digital Ally, its wholly-owned subsidiaries, Digital Ally International,
Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu
Jets, Inc., Kustom 440, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC. All intercompany balances and transactions
have been eliminated during consolidation.
The
Company formed Digital Ally International, Inc. during August 2009 to facilitate the export sales of its products. The Company formed
Shield Products, LLC in May 2020 to facilitate the sales of its Shield™ line of disinfectant/cleanser products and ThermoVu™
line of temperature monitoring equipment. The Company formed Nobility Healthcare, LLC (“Nobility Healthcare”) in June 2021
to facilitate the operations of its revenue cycle management solutions and back-office services for healthcare organizations. The Company
formed TicketSmarter, Inc. upon its acquisition of Goody Tickets, LLC and TicketSmarter, LLC, to facilitate its global ticketing operations.
The Company formed Worldwide Reinsurance Ltd., which is a captive insurance company domiciled in Bermuda. It will provide primarily liability
insurance coverage to the Company for which insurance may not be currently available or economically feasible in today’s insurance
marketplace. The Company formed Kustom 440, Inc. in 2022 to create unique entertainment experiences directly for consumers, and Kustom
Entertainment, Inc. in 2023 to serve as the participant in the Business Combination.
Fair
Value of Financial Instruments:
The
carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and
notes payable approximate fair value because of the short-term nature of these items.
Revenue
Recognition:
The
Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all
related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers
in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies
the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract,
(3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize
revenue when a performance obligation is satisfied.
The
Company has two different revenue streams, product and service, represented through its three segments. The Company reports all revenues
on a gross basis, other than service revenues from the Company’s entertainment and revenue cycle management segments, Revenues
generated by all segments are reported net of sales taxes.
Video
Solutions
The
Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the
customer. In situation where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company
holds a contract bearing enforceable rights and obligations only with the distributor. As part of part of its consideration for the contract,
the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company
considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the
transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which
it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient
under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction
price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is
considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar
circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e. when the Company’s performance
obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company
considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the
customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair
services or replacement products. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for
product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than
one year.
Service
and other revenue is comprised of revenues from extended warranties, repair services, cloud revenue and software revenue. Revenue is
recognized upon shipment of the product and acceptance of the service or materials by the end customer for repair services. Revenue for
extended warranty, cloud service or other software-based products is over the term of the contract warranty or service period. A time-elapsed
method is used to measure progress because the Company transfers control evenly over the contractual period. Accordingly, the fixed consideration
related to these revenues is generally recognized on a straight-line basis over the contract term, as long as the other revenue recognition
criteria have been met.
The
Company’s multiple performance obligations may include future in-car or body-worn camera devices to be delivered at defined points
within a multi-year contract, and in those arrangements, the Company allocates total arrangement consideration over the life of the multi-year
contract to future deliverables using management’s best estimate of selling price.
Revenue
Cycle Management
The
Company reports revenue cycle management revenues on a net basis, as its primary source of revenue is its end-to-end service fees which
is generally determined as a percentage of the invoice amounts collected. These service fees are reported as revenue monthly upon completion
of the Company’s performance obligation to provide the agreed upon service.
Entertainment
The
Company reports ticketing revenue on a gross or net basis based on management’s assessment of whether the Company is acting as
a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the
right to sell the ticket, prior to its transfer to the ticket buyer.
The
Company sells tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to
the buyer upon confirmation of the order. The Company acts as the principal in these transactions as the ticket is owned by the Company
at the time of sale, therefore controlling the ticket prior to transferring to the customer. In these transactions, revenue is recorded
on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery
of the ticket.
The
Company also acts as an intermediary between buyers and sellers through online secondary marketplace. Revenues derived from this marketplace
primarily consist of service fees from ticketing operations, and consists of one primary performance obligation, which is facilitating
the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As the Company does not control
the ticket prior to the transfer, the Company acts as an agent in these transactions. Revenue is recognized on a net basis, net of the
amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s
listing. Payment is due at the time of sale.
Other
Contract
liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately
as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts,
prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied.
During the six months ended June 30, 2024, the Company recognized revenue of $1.4 million related to its contract liabilities. Contract
liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately
as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts,
prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied.
Total contract liabilities consist of the following:
SCHEDULE OF CONTRACT LIABILITIES
| |
June 30, 2024 | |
| |
December 31, 2023 | | |
Additions/ Reclass | | |
Recognized Revenue | | |
June 30, 2024 | |
Contract liabilities, current | |
$ | 2,937,168 | | |
$ | 767,131 | | |
$ | (610,807 | ) | |
$ | 3,093,492 | |
Contract liabilities, non-current | |
| 7,340,459 | | |
| 412,632 | | |
| (753,950 | ) | |
| 6,999,141 | |
| |
| | | |
| | | |
| | | |
| | |
| |
$ | 10,277,627 | | |
$ | 1,179,763 | | |
$ | (1,364,757 | ) | |
$ | 10,092,633 | |
| |
June 30, 2023 | |
| |
December 31, 2022 | | |
Additions/ Reclass | | |
Recognized Revenue | | |
June 30, 2023 | |
Contract liabilities, current | |
$ | 2,154,874 | | |
$ | 1,246,212 | | |
$ | (496,034 | ) | |
$ | 2,905,052 | |
Contract liabilities, non-current | |
| 5,818,082 | | |
| 1,223,497 | | |
| (487,106 | ) | |
| 6,554,473 | |
| |
| | | |
| | | |
| | | |
| | |
| |
$ | 7,972,956 | | |
$ | 2,469,709 | | |
$ | (983,140 | ) | |
$ | 9,459,525 | |
Sales
returns and allowances aggregated $93,170 and $117,713 for the six months ended June 30, 2024 and December 31, 2023, respectively. Obligations
for estimated sales returns and allowances are recognized at the time of sales on an accrual basis. The accrual is determined based upon
historical return rates adjusted for known changes in key variables affecting these return rates.
Use
of Estimates:
The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during
the reporting period. Actual results could differ from those estimates. Management utilizes various other estimates, including but not
limited to determining the estimated lives of long-lived assets, determining the potential impairment of long-lived assets, the fair
value of warrants, options, the recognition of revenue, inventory valuation reserve, fair value of assets and liabilities acquired in
a business combination, incremental borrowing rate on leases, the valuation allowance for deferred tax assets and other legal claims
and contingencies. The results of any changes in accounting estimates are reflected in the financial statements in the period in which
the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period
that they are determined to be necessary.
Cash
and cash equivalents:
Cash
and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less.
SCHEDULE OF SHORT TERM INVESTMENTS
| |
June
30, 2024 | |
| |
Adjusted
Cost | | |
Realized
Gains | | |
Realized
Losses | | |
Fair
Value | |
Demand
deposits | |
$ | 439,881 | | |
$ | — | | |
$ | — | | |
$ | 439,881 | |
Short-term
investments with original maturities of 90 days or less (Level 1): | |
| | | |
| | | |
| | | |
| | |
Money
market funds | |
| 77,232 | | |
| — | | |
| — | | |
| 77,232 | |
| |
| | | |
| | | |
| | | |
| | |
| |
$ | 517,113 | | |
$ | — | | |
$ | — | | |
$ | 517,113 | |
| |
December
31, 2023 | |
| |
Adjusted
Cost | | |
Unrealized
Gains | | |
Unrealized
Losses | | |
Fair
Value | |
Demand
deposits | |
$ | 545,207 | | |
$ | — | | |
$ | — | | |
$ | 545,207 | |
Short-term
investments with original maturities of 90 days or less (Level 1): | |
| | | |
| | | |
| | | |
| | |
Money
market funds | |
| 135,342 | | |
| — | | |
| — | | |
| 135,342 | |
| |
| | | |
| | | |
| | | |
| | |
| |
$ | 680,549 | | |
$ | — | | |
$ | — | | |
$ | 680,549 | |
The
Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that
at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits
with major financial institutions. At June 30, 2024 and December 31, 2023, the uninsured balance amounted to $136,717 and $29,700, respectively.
Restricted
Cash:
Restricted
cash of $97,600 and $97,600 was included in other assets as of June 30, 2024 and December 31, 2023, respectively. Restricted cash consists
of bank deposits that collateralize our debt obligations.
The
following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and
restricted cash in the consolidated statements of cash flows:
SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS
| |
June 30, 2024 | | |
December 31, 2023 | |
Cash and cash equivalents | |
$ | 517,113 | | |
$ | 680,549 | |
Long-term restricted cash included in other assets | |
| 97,600 | | |
| 97,600 | |
Total cash, cash equivalents and restricted cash in the statements of cash flows | |
$ | 614,713 | | |
$ | 778,149 | |
Accounts
Receivable:
Accounts
receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding
amounts on a weekly basis. The Company determines the allowance for doubtful accounts by regularly evaluating individual customer receivables
and considering a customer’s financial condition, credit history, and current economic conditions.
Trade
receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.
A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than thirty (30) days
beyond terms. No interest is charged on overdue trade receivables.
Goodwill
and Other Intangibles:
Goodwill
- In connection with acquisitions, the Company applies the provisions of ASC 805, Business Combinations, using the acquisition
method of accounting. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired
is recorded as goodwill. In accordance with ASC 350, Intangibles - Goodwill and Other, the Company assesses goodwill for impairment
annually as of December 31, and more frequently if events and circumstances indicate that goodwill might be impaired.
Goodwill
impairment testing is performed at the reporting unit level. Goodwill is assigned to reporting units at the date the goodwill is initially
recorded. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and
all of the activities within a reporting unit, whether acquired or internally generated, are available to support the value of the goodwill.
Traditionally,
goodwill impairment testing is a two-step process. Step one involves comparing the fair value of the reporting units to its carrying
amount. If the carrying amount of a reporting unit is greater than zero and its fair value is greater than its carrying amount, there
is no impairment. If the reporting unit’s carrying amount is greater than the fair value, the second step must be completed to
measure the amount of impairment, if any. Step two involves calculating an implied fair value of goodwill. The Company has adopted ASU
2017-04 which simplifies subsequent goodwill measurement by eliminating step two from the goodwill impairment test. As a result, the
Company compares the fair value of a reporting unit with its respective carrying value and recognized an impairment charge for the amount
by which the carrying amount exceeded the reporting unit’s fair value.
The
Company determines the fair value of its reporting units using the market approach. Under the market approach, we estimate the fair value
based on multiples of comparable public companies and precedent transactions. Significant estimates in the market approach include: identifying
similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing
comparable revenue and operating income multiples in estimating the fair value of the reporting unit.
Long-lived
and Other Intangible Assets - The Company periodically assesses potential impairments of its long-lived assets in accordance with
the provisions of ASC 360, Accounting for the Impairment or Disposal of Long-lived Assets. An impairment review is performed whenever
events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The Company groups its assets
at the lowest level for which identifiable cash flows are largely independent of the cash flows of the other assets and liabilities.
The Company has determined that the lowest level for which identifiable cash flows are available is the operating segment level.
Factors
considered by the Company include, but are not limited to, significant underperformance relative to historical or projected operating
results; significant changes in the manner of use of the acquired assets or the strategy for the overall business; and significant negative
industry or economic trends. When the carrying value of a long-lived asset may not be recoverable based upon the existence of one or
more of the above indicators of impairment, the Company estimates the future undiscounted cash flows expected to result from the use
of the asset and its eventual disposition. If the sum of the expected future undiscounted cash flows and eventual disposition is less
than the carrying amount of the asset, the Company recognizes an impairment loss. An impairment loss is reflected as the amount by which
the carrying amount of the asset exceeds the fair value of the asset, based on the fair value if available, or discounted cash flows,
if fair value is not available. The Company last assessed potential impairments of its long-lived assets as of December 31, 2023 and
concluded that there was no impairment. Subsequent to completing our 2023 annual impairment test, no events or changes in circumstances
were noted that required an interim goodwill impairment test.
Intangible
assets include deferred patent costs, license agreements, trademarks and trade names. Legal expenses incurred in preparation of patent
application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications
that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which
it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require
upfront payments to obtain the exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and
amortizes such costs over their estimated useful life on a straight-line method.
Segment
Reporting
The
accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial
statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified
as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision
maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess
performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which
has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate
administrative activities and are also to be reported in the segment information.
Contingent
Consideration
In
circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under the
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities
from Equity, the Company recognizes a liability equal to the fair value of the contingent payments the Company expects to make as of
the acquisition date. The Company remeasures this liability each reporting period and records changes in the fair value through the consolidated
statement of operations.
Non-Controlling
Interests
Non-controlling
interests in the Company’s Consolidated Financial Statements represent the interest in subsidiaries held by our venture partner.
The venture partner holds a noncontrolling interest in the Company’s consolidated subsidiary Nobility Healthcare, LLC. Since the
Company consolidates the financial statements of all wholly-owned and majority owned subsidiaries, the noncontrolling owners’ share
of each subsidiary’s results of operations are deducted and reported as net income or loss attributable to noncontrolling interest
in the Consolidated Statements of Operations.
New
Accounting Standards
In
November 2023, the FASB issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable
Segment Disclosures” (“ASU 2023-07”), which is intended to improve reportable segment disclosure requirements, primarily
through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December
15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to
be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories
and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in
the period of adoption. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial
statements and related disclosures.
In
December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”
(“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories
in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between
domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU
2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among
other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual
financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis,
but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated
financial statements and related disclosures.
NOTE
2. INVENTORIES
Inventories
consisted of the following at June 30, 2024 and December 31, 2023:
SCHEDULE OF INVENTORIES
| |
June
30, 2024 | | |
December
31, 2023 | |
Raw material and component parts– video solutions segment | |
$ | 2,614,267 | | |
$ | 3,044,653 | |
Work-in-process– video solutions segment | |
| 15,895 | | |
| 20,396 | |
Finished goods – video solutions segment | |
| 3,436,629 | | |
| 4,623,489 | |
Finished goods – entertainment segment | |
| 286,343 | | |
| 699,204 | |
Subtotal | |
| 6,353,134 | | |
| 8,387,742 | |
Reserve for excess and obsolete inventory– video solutions segment | |
| (4,008,278 | ) | |
| (4,355,666 | ) |
Reserve for excess and obsolete inventory – entertainment segment | |
| (126,723 | ) | |
| (186,795 | ) |
Total inventories | |
$ | 2,218,133 | | |
$ | 3,845,281 | |
Finished
goods inventory includes units held by potential customers and sales agents for test and evaluation purposes. The cost of such units
totaled $43,274 and $42,797 as of June 30, 2024 and December 31, 2023, respectively.
NOTE
3. DEBT OBLIGATIONS
Debt
obligations is comprised of the following:
SCHEDULE OF DEBT OBLIGATIONS
| |
June 30, 2024 | | |
December 31, 2023 | |
Economic injury disaster loan (EIDL) | |
$ | 146,154 | | |
$ | 147,781 | |
Contingent consideration promissory note – Nobility Healthcare Division Acquisition | |
| — | | |
| 129,651 | |
Contingent consideration promissory note – Nobility Healthcare Division Acquisition | |
| — | | |
| 58,819 | |
Revolving Loan Agreement | |
| 4,880,000 | | |
| 4,880,000 | |
Commercial Extension of Credit- Entertainment Segment | |
| 12,500 | | |
| 87,928 | |
Merchant Advances – Video Solutions Segment | |
| 2,259,000 | | |
| 1,350,000 | |
Merchant Advances – Entertainment Segment | |
| 1,373,101 | | |
| — | |
Unamortized debt issuance costs | |
| (791,434 | ) | |
| (540,429 | ) |
Debt obligations | |
| 7,879,321 | | |
| 6,113,750 | |
Less: current maturities of debt obligations | |
| 2,980,903 | | |
| 1,260,513 | |
Debt obligations, long-term | |
$ | 4,898,418 | | |
$ | 4,853,237 | |
Debt
obligations mature as follows as of June 30, 2024:
SCHEDULE OF MATURITY OF DEBT OBLIGATIONS
| |
June 30, 2024 | |
2024 (July 1, 2024 to December 31, 2024) | |
$ | 2,979,213 | |
2025 | |
| 4,759,024 | |
2026 | |
| 3,542 | |
2027 | |
| 3,677 | |
2028 and thereafter | |
| 133,865 | |
| |
| | |
Total | |
$ | 7,879,321 | |
2020
Small Business Administration Notes.
On
May 12, 2020, the Company received $150,000 in loan funding from the SBA under the Economic Injury Disaster Loan (“EIDL”)
program administered by the SBA, which program was expanded pursuant to the recently enacted CARES Act. The EIDL is evidenced by a secured
promissory note, dated May 8, 2020, in the original principal amount of $150,000 with the SBA, the lender.
Under
the terms of the note issued under the EIDL program, interest accrues on the outstanding principal at the rate of 3.75% per annum. The
term of such note is thirty years, though it may be payable sooner upon an event of default under such note. Monthly principal and interest
payments began in November 2022, after being deferred for thirty months after the date of disbursement and total $731 per month thereafter.
Such note may be prepaid in part or in full, at any time, without penalty. The Company granted the SBA a continuing interest in and to
any and all collateral, including but not limited to tangible and intangible personal property.
The
Company made principal payments of $1,628 during the six months ended June 30, 2024 and recorded interest expense of $1,383 and $2,758
for the three and six months ended June 30, 2024.
Contingent
Consideration Promissory Notes
On
June 30, 2021, Nobility Healthcare, a subsidiary of the Company, issued a contingent consideration promissory note (the “June Contingent
Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “June Seller”)
of $350,000. The June Contingent Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and
interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter.
The principal amount of the June Contingent Note is subject to an earn-out adjustment, being the difference between $975,000 (the “June
Projected Revenue”) and the cash basis revenue (the “June Measurement Period Revenue”) collected by the June Seller
in its normal course of business from the clients existing on June 30, 2021, during the period from October 1, 2021 through September
30, 2022 (the “June Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the June
Measurement Period Revenue is less than the June Projected Revenue, such amount will be subtracted from the principal balance of this
June Contingent Note on a dollar-for-dollar basis. If the June Measurement Period Revenue is more than the June Projected Revenue, such
amount will be added to the principal balance of this June Contingent Note on a dollar-for-dollar basis. In no event will the principal
balance of this June Contingent Note become a negative number. The maximum downward earn-out adjustment to the principal balance will
be a reduction to zero. There are no limits to the increases to the principal balance of the June Contingent Note as a result of the
earn-out adjustments.
The
June Contingent Note is considered to be additional purchase price; therefore, the estimated fair value of the contingent liability is
recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition with
subsequent changes in fair value recorded as a gain or loss in the Consolidated Statements of Operations. Management recorded the contingent
consideration promissory note at its estimated fair value of $350,000
at the acquisition date. Total principal payments,
since inception, on this contingent consideration promissory note totaled $290,952.
The estimated fair value of the June Contingent
Note at June 30, 2024 is $-0-,
representing a reduction in its estimated fair value of $58,819
as compared to its estimated fair value as of
December 31, 2023. This reduction only relates to the principal payments made for the six months ended June 30, 2024. Therefore, the
Company recorded no gain or loss in the Consolidated Statements of Operations for the six months ended June 30, 2024.
On
August 31, 2021, Nobility Healthcare, issued another contingent consideration promissory note (the “August Contingent Payment Note”)
in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “August Sellers”) of
$650,000. The August Contingent Payment Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal
and interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter.
The principal amount of the August Contingent Payment Note is subject to an earn-out adjustment, being the difference between the $3,000,000
(the “August Projected Revenue”) and the cash basis revenue (the “August Measurement Period Revenue”) collected
by the August Sellers in its normal course of business from the clients existing on September 1, 2021, during the period from December
1, 2021 through November 30, 2022 (the “August Measurement Period”) measured on a quarterly basis and annualized as of the
relevant period. If the August Measurement Period Revenue is less than the August Projected Revenue, such amount will be subtracted from
the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. If the August Measurement Period Revenue is
more than the August Projected Revenue, such amount will be added to the principal balance of this August Contingent Payment Note on
a dollar-for-dollar basis. In no event will the principal balance of this August Contingent Payment Note become a negative number. The
maximum downward earn-out adjustment to the principal balance will be to zero. There are no limits to the increases to the principal
balance of the August Contingent Payment Note as a result of the earn-out adjustments.
The
August Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the contingent liability
is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition.
Management has recorded the contingent consideration promissory note at its estimated fair value of $650,000 at the acquisition date.
Principal payments, since its inception, on this contingent consideration promissory note totaled $681,907. The estimated fair value
of the August Contingent Note at June 30, 2024 is $-0-, representing a decrease in its estimated fair value of $129,651 as compared to
is estimated fair value as of December 31, 2023. This reduction only relates to the principal payments made for the six months ended
June 30, 2024. Therefore, the Company recorded no gain or loss in the Consolidated Statements of Operations for the six months ended
June 30, 2024.
2023
Commercial Extension of Credit
On
February 23, 2023, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing
and operating its business in accordance with the Private Label Agreement previously entered into with the Lender. The Lender agreed
to extend, subject to the conditions hereof, and Borrower agreed to take, a Loan for Principal Sum of $1,000,000.
Lender
shall retain 25% of each remittance owed to Borrower under the terms of the Private Label Agreement. Such remittances shall include regular
weekly remittances and any additional incentive payments to which the Borrower may be entitled. The 25% withholding of the Borrower’s
applicable remittance shall be deemed a “Payment” under the terms of this Note, and Payments shall continue until the earlier
of (i) repayment of the Principal Sum, accrued Interest, and a fee of $35,000 or (ii) expiration of the Private Label Agreement on December
31, 2023.
During
the six months ended June 30, 2024, the Entertainment segment Company’s Entertainment segment repaid the outstanding principal
of $87,928 and did not renew this agreement.
2024
Commercial Extension of Credit
On
January 22, 2024, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing
and operating its business in accordance with the Ticket Solution Agreement. The Lender, Ticket Evolution, Inc., agreed to extend, subject
to the conditions hereof, and Borrower agreed to take, a Loan for Principal Sum of $75,000 with monthly advances of $100,000.
The
advances made are recoupable from client service fees with no more than $25,000 being recouped in any one week. The total advances received
for the six months ended June 30, 2024 were $575,000 and payments made totaled $562,500. The outstanding balance as of June 30, 2024 was
$12,500.
Convertible
Note
On
April 5, 2023, the Company entered into and consummated the initial closing (the “First Closing”) of the transactions contemplated
by a Securities Purchase Agreement, dated as of April 5, 2023 (the “Purchase Agreement”), between the Company and certain
investors (the “Purchasers”).
At
the First Closing, the Company issued and sold to the Purchasers Senior Secured Convertible Notes in the aggregate original principal
amount of $3,000,000 (the “Notes”) and warrants (the “Warrants”). The Purchase Agreement provided for a ten percent
(10%) original interest discount resulting in gross proceeds to the Company of $2,700,000. No interest accrues under the Notes. The Warrants
are exercisable for an aggregate 1,125,000 shares comprised of 375,000 warrants at an exercise price of $5.50 per share of the Company’s
common stock, par value $0.001 (the “Common Stock”), 375,000 warrants at an exercise price of $6.50 per share of Common Stock,
and 375,000 warrants at an exercise price of $7.50 per share of Common Stock.
Subject
to certain conditions, within 18 months from the effectiveness date and while the Notes remain outstanding, the Purchasers have the right
to require the Company to consummate a second closing of up to an additional $3,000,000 of Notes (the “Second Notes”) and
Warrants on the same terms and conditions as the First Closing, except that the Second Notes may be subordinate to a mortgage on the
Company’s headquarters building (the “Bank Mortgage”).
The
Notes are convertible into shares of Common Stock at the election of the Purchasers at any time at a fixed conversion price of $5.00
(the “Conversion Price”) per share of Common Stock. The Conversion Price is subject to customary adjustments for stock dividends,
stock splits, reclassifications and the like, and subject to price-based adjustment in the event of any issuances of Common Stock, or
securities convertible, exercisable or exchangeable for, Common Stock at a price below the then-applicable Conversion Price (subject
to certain exceptions). Subject to certain conditions, including certain equity conditions, the Company may redeem some or all of the
then outstanding principal amount of the Note for cash in an amount equal to 110% of the outstanding principal amount of the Notes (the
“Optional Redemption Amount”). In addition, the Purchasers may, at their option, demand repayment at the Optional Redemption
Amount upon five (5) business days’ written notice following (i) the closing by the Company of the Bank Mortgage, or (ii) a sale
by the Company of Common Stock or Common Stock equivalents.
The
Notes rank senior to all outstanding and future indebtedness of the Company and its subsidiaries, and are secured by substantially all
of the Company’s assets, as evidenced by (i) a security agreement entered into at the Closing, (ii) a trademark security agreement
entered into at the Closing, (iii) a patent security agreement entered into at the Closing, (iv) a guaranty executed by all direct and
indirect subsidiaries of the Company pursuant to which each of them has agreed to guaranty the obligations of the Company under the Notes,
and (v) a mortgage on the Company’s headquarters building in favor of the Purchasers.
Also
at the Closing, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers.
Pursuant to the terms of the Registration Rights Agreement, the Company has agreed to prepare and file with the SEC within the 10th business
day following the First Closing (the “Filing Date”) a registration statement covering the resale of the shares of Common
Stock issuable upon conversion of the Notes and exercise of the Warrants, and to use its best efforts to cause such Registration Statement
to be declared effective under the Securities Act of 1933, as amended (the “Securities Act”), as promptly as possible, but
in any event no later than 45 days following the Filing Date (the “Effectiveness Date”). If the Registration Statement is
not filed by the Filing Date or is not declared effective by the Effectiveness Date, or under certain other circumstances described in
the Registration Rights Agreement, then the Company shall be obligated to pay, as partial liquidated damages, to each Purchaser an amount
in cash equal to 2% of the original principal amount of the Notes each month until the applicable event giving rise to such payments
is cured. If the Company fails to pay any partial liquidated damages in full within seven days after the date payable, the Company will
pay interest thereon at a rate of 10% per annum.
The
Company recognized the full warrant derivative value, with the remaining amount being allocated to the debt obligation. As the warrant
derivative value exceeded the net proceeds from the issuance, the excess amount is recognized as a loss on the date of the issue date.
Thus, the Company recorded a loss of $576,380 as an interest expense on the date of issuance relating to the Notes. The following is
the assumptions used in calculating the estimated grant-date fair value of the detachable warrants to purchase common stock granted in
connection with the Notes:
SCHEDULE OF WARRANT TO PURCHASE COMMON STOCK GRANTED
| |
Terms at April 5, 2023 (issuance date) | |
Volatility - range | |
| 106.0 | % |
Risk-free rate | |
| 3.36 | % |
Dividend | |
| 0 | % |
Remaining contractual term | |
| 5.0 years | |
Exercise price | |
$ | 5.50 – 7.50 | |
Common stock issuable under the warrants | |
| 1,125,000 | |
On
June 2, 2023, the Purchasers elected to convert $125,000 principal, at the fixed price of $5.00 per share of common stock, 25,000 shares
valued at $119,750. The loss on conversion of convertible note into common shares, of $93,386, was recorded during the period.
On
October 26, 2023, the Company entered into a Revolving Loan Agreement of which a portion of the net proceeds were used to repay the principal
amount of the Convertible debt. The warrants associated with the convertible debt remain outstanding.
Revolving
Loan Agreement
On
October 26, 2023, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) by and between the Company,
Digital Ally Healthcare, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Digital Ally Healthcare”
and, together with the Company, the “Borrower”), and Kompass Kapital Funding, LLC, a Kansas limited liability company (“Kompass”).
In connection with the Loan Agreement, on October 26, 2023, the Company entered into a Mortgage, Assignment of Leases and Rents, Security
Agreement and Fixture Filing (the “Mortgage”) by and between the Company, as grantor, and Kompass, as grantee, and issued
a Revolving Note (the “Revolving Note”) to Kompass. The gross proceeds to the Company were $4,880,000 before repaying those
certain Senior Secured Convertible Notes issued on April 5, 2023 in the aggregate amount of $3,162,500 and paying customary fees and
expenses.
Pursuant
to the Loan Agreement, Kompass agreed to make revolving loans (the “Revolving Loans”) available to the Borrower as the Borrower
may from time to time request until, but not including, October 26, 2025, and in such amounts as the Borrower may from time to time request,
provided, however, that the aggregate principal balance of the Revolving Loans outstanding at any time shall not exceed the lesser of
$4,880,000 or an amount equal to eighty percent of the value of the mortgaged property, which consists of the real property owned by
the Company having an address of 14001 Marshall Drive, Lenexa, KS 66215 (the “Mortgaged Property”). Under the Loan Agreement,
the Revolving Loans made by Kompass may be repaid and, subject to customary terms and conditions, borrowed again up to, but not including
October 26, 2025, unless the Revolving Loans are otherwise accelerated, terminated or extended as provided in the Loan Agreement. The
Revolving Loans shall be used by the Borrower for the purpose of working capital and to retire existing debt. Under the Loan Agreement,
the Borrower is required to provide written notice to Kompass prior to creating, assuming or incurring any debt or becoming liable, whether
as endorser, guarantor, surety or otherwise, for any debt or obligation of any other party. While obligations remain outstanding under
the Loan Agreement, the Borrower is required to maintain a minimum balance of $97,600 in a reserve account (the “Capital Reserve
Account”). Under the Loan Agreement, the Borrower is prohibited from creating, assuming, incurring or suffering or permitting to
exist any lien of any kind or character upon the collateral, which consists of the Mortgaged Property and the Company’s interest
in the Capital Reserve Account. The Loan Agreement contains customary covenants, representations and warranties by the Borrower.
Pursuant
to the Loan Agreement, the Company issued the Revolving Note to Kompass whereby the Company and Digital Ally Healthcare jointly and severally
promise to pay to the order of Kompass the lesser of (i) $4,880,000.00, or (ii) the aggregate principal amount of all Revolving Loans
outstanding under and pursuant to the Loan Agreement at the maturity or maturities and in the amount or amounts stated on the records
of Kompass, together with interest (computed on the actual number of days elapsed on the basis of a 360 day year) at a floating per annum
rate equal to the greater of (i) the Prime Rate plus four percent or (ii) eight percent, on the aggregate principal amount of all Revolving
Loans outstanding from time to time as provided in the Loan Agreement.
The
Company entered into the Mortgage to secure its obligations under the Loan Agreement. The property mortgaged under the Mortgage consists
of the Mortgaged Property. The Mortgage contains customary covenants, representations and warranties by the Company. In addition, the
Company recorded debt issuance costs of $188,255. During the three and six months ended June 30, 2024, the Company amortized $23,435
and $46,871 of debt discount under interest expense.
Merchant
Cash Advances – Video Solutions Segment
In
November 2023, the Company obtained a short-term merchant advance, which totaled $1,050,000, from a single lender to fund operations.
These advances included origination fees totaling $50,000 for net proceeds of $1,000,000. The advance is, for the most part, secured
by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of
$1,512,000 to the lender. The loan bears interest at 2.9% per week. During the six months ended June 30, 2024, the Company made repayments
totaling $1,215,000 and received additional proceeds of $1,144,000. The Company refinanced this loan in April 2024 resulting in the additional
proceeds. The refinancing was deemed to be an extinguishment of debt and a loss on extinguishment of debt was recorded during the three
months ended June 30, 2024 of $68,827.
As
of June 30, 2024 the outstanding balance was $2,259,000 which is expected to be repaid in 2024.
During
the six months ended June 30, 2024 the Company amortized $820,429 of debt discount under interest expense.
Merchant
Cash Advances – Entertainment Segment
In
March 2024, the Company obtained a short-term merchant advance, which totaled $1,000,000, from a single lender to fund operations. These
advances included origination and issuance fees totaling $85,000 for net proceeds of $915,000. The advance is, for the most part, is
secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate
of $1,425,000 to the lender. The loan bears interest at 5.19% per month. During the six months ended June 30, 2024, the Company made
repayments totaling $51,899. As of June 30, 2024 the outstanding balance was $1,373,101 which is expected to be repaid in 2024.
During
the three and six months ended June 30, 2024 the Company amortized $139,118 and $202,868 of debt discount and issuance costs under interest
expense.
NOTE
4. FAIR VALUE MEASUREMENT
In
accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the
market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information
generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a
business.
ASC
820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels.
The following is a brief description of those three levels:
● |
Level
1 — Quoted prices in active markets for identical assets and liabilities |
|
|
● |
Level
2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities) |
|
|
● |
Level
3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value) |
The
following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring
basis as of June 30, 2024 and December 31, 2023:
SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS
| |
June 30, 2024 | |
| |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Warrant derivative liabilities | |
$ | — | | |
$ | — | | |
$ | 3,796,746 | | |
$ | 3,796,746 | |
Contingent consideration promissory notes and contingent consideration earn-out agreement | |
| — | | |
| — | | |
| — | | |
| — | |
| |
$ | — | | |
$ | — | | |
$ | 3,796,746 | | |
$ | 3,796,746 | |
| |
December 31, 2023 | |
| |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Warrant derivative liabilities | |
$ | — | | |
$ | — | | |
$ | 1,369,738 | | |
$ | 1,369,738 | |
Contingent consideration promissory notes and contingent consideration earn-out agreement | |
| — | | |
| — | | |
| 188,470 | | |
| 188,470 | |
| |
$ | — | | |
$ | — | | |
$ | 1,558,208 | | |
$ | 1,558,208 | |
The
following table represents the change in Level 3 tier value measurements for the three months ended June 30, 2024:
SCHEDULE OF FAIR VALUE MEASUREMENTS CHANGE IN LEVEL 3 INPUTS
| |
Contingent Consideration Promissory Notes and Earn-Out Agreement | | |
Warrant Derivative Liabilities | |
| |
| | |
| |
Balance, December 31, 2023 | |
$ | 188,470 | | |
$ | 1,369,738 | |
| |
| | | |
| | |
Issuance of warrant derivative liabilities | |
| | | |
| 2,075,300 | |
| |
| | | |
| | |
Change in fair value of warrant derivative liabilities | |
| — | | |
| 351,710 | |
| |
| | | |
| | |
Principal payments on contingent consideration promissory notes – Revenue Cycle Management Acquisitions | |
| (188,470 | ) | |
| — | |
| |
| | | |
| | |
Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions | |
| — | | |
| — | |
| |
| | | |
| | |
Balance, June 30, 2024 | |
$ | — | | |
$ | 3,796,748 | |
NOTE
5. ACCRUED EXPENSES
Accrued
expenses consisted of the following at June 30, 2024 and December 31, 2023:
SCHEDULE OF ACCRUED EXPENSES
| |
June 30, 2024 | | |
December 31, 2023 | |
Accrued warranty expense | |
$ | 11,615 | | |
$ | 17,699 | |
Accrued litigation costs | |
| 2,040,292 | | |
| 2,040,292 | |
Accrued sales commissions | |
| 1,465 | | |
| 87,421 | |
Accrued payroll and related fringes | |
| 420,596 | | |
| 367,826 | |
Accrued sales returns and allowances | |
| 93,170 | | |
| 117,713 | |
Accrued taxes | |
| 161,639 | | |
| 150,981 | |
Accrued interest - related party | |
| 283,782 | | |
| 95,031 | |
Customer deposits | |
| 75,283 | | |
| 219,462 | |
Other | |
| 292,163 | | |
| 172,905 | |
Total accrued
expenses | |
$ | 3,380,005 | | |
$ | 3,269,330 | |
Accrued
warranty expense was comprised of the following for the six months ended June 30, 2024:
SCHEDULE OF ACCRUED WARRANTY EXPENSE
Beginning balance | |
$ | 17,699 | |
Provision for warranty expense | |
| 38,898 | |
Charges applied to warranty reserve | |
| (44,982 | ) |
| |
| | |
Ending balance | |
$ | 11,615 | |
NOTE
6. INCOME TAXES
The
effective tax rate for the three and six months ended June 30, 2024 and 2023 varied from the expected statutory rate due to the Company
continuing to provide a 100% valuation allowance on net deferred tax assets. The Company determined that it was appropriate to continue
the full valuation allowance on net deferred tax assets as of June 30, 2024, primarily because of the Company’s history of operating
losses.
The
Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at June 30, 2024.
Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh
the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it is determined
to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full
valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets.
To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected
future taxable income, a portion or all of the valuation allowance will be reversed. The Company has available to it approximately $140.9
million (based on its December 31, 2023 tax return) in net operating loss carryforwards to offset future taxable income as of June 30,
2024.
NOTE
7. PREPAID EXPENSES
Prepaid
expenses were the following at June 30, 2024 and December 31, 2023:
SCHEDULE OF PREPAID EXPENSE
| |
June 30, 2024 | | |
December 31, 2023 | |
Prepaid inventory | |
$ | 5,200,463 | | |
$ | 5,318,939 | |
Prepaid advertising | |
| 410,226 | | |
| 612,292 | |
Other | |
| 1,009,788 | | |
| 435,137 | |
Total prepaid expenses | |
$ | 6,620,477 | | |
$ | 6,366,368 | |
NOTE
8. PROPERTY, PLANT AND EQUIPMENT
Property,
plant and equipment consisted of the following at June 30, 2024 and December 31, 2023:
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT
| |
Estimated Useful Life | |
June 30, 2024 | | |
December 31, 2023 | |
Building | |
25 years | |
$ | 4,537,037 | | |
$ | 4,537,037 | |
Land | |
Infinite | |
| 739,734 | | |
| 739,734 | |
Office furniture, fixtures, equipment, and aircraft | |
3-20 years | |
| 779,879 | | |
| 2,065,092 | |
Warehouse and production equipment | |
3-7 years | |
| 237,141 | | |
| 29,055 | |
Demonstration and tradeshow equipment | |
3-7 years | |
| 77,791 | | |
| 87,987 | |
Building improvements | |
5-7 years | |
| 1,341,471 | | |
| 1,328,654 | |
Total cost | |
| |
| 7,713,053 | | |
| 8,787,559 | |
Less: accumulated depreciation and amortization | |
| |
| (1,679,962 | ) | |
| (1,503,857 | ) |
| |
| |
| | | |
| | |
Net property, plant and equipment | |
| |
$ | 6,033,091 | | |
$ | 7,283,702 | |
Depreciation
expense for the three months ended June 30, 2024 and June 30, 2023 was $181,121 and $174,261, respectively, and is included in general
and administrative expenses. Depreciation expense for the six months ended June 30, 2024 and June 30, 2023 was $343,833 and $345,892,
respectively, and is included in general and administrative expenses.
During
the six months ended June 30, 2024 the Company engaged a broker and sold its aircraft for $1,100,000 less closing costs of $1,500. The
carrying amount of the aircraft on the date of sale was $1,141,661. As a result of the sale the Company recorded a loss of $41,661 in
the Consolidated Statement of Operations.
NOTE
9. OPERATING LEASE
The
Company entered into an operating lease with a third party in October 2023 for copiers used for office and warehouse purposes. The terms
of the lease include 48 monthly payments of $1,786 with a maturity date of October 2027. The Company has the option to purchase such
equipment at maturity for its estimated fair market value at that point in time. The remaining lease term for the Company’s copier
operating lease as of June 30, 2024 was forty months.
On
May 13, 2020, the Company entered into an operating lease for new warehouse and office space, which served as its new principal executive
office and primary business location. The original lease agreement was amended on August 28, 2020 to correct the footage under lease
and monthly payment amounts resulting from such correction. The lease terms, as amended include no base rent for the first nine months
and monthly payments ranging from $12,398 to $14,741 thereafter, with a termination date of December 2026. The Company is responsible
for property taxes, utilities, insurance and its proportionate share of common area costs related to its new location. The Company took
possession of the leased facilities on June 15, 2020. The remaining lease term for the Company’s office and warehouse operating
lease as of June 30, 2024 was thirty months.
On
June 30, 2021, the Company completed the acquisition of its first medical billing company, through Nobility Healthcare. Upon
completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space.
The lease terms include monthly payments ranging from $2,648
to $2,774
thereafter, with a termination
date in July 2024. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common
area costs related to this location. The remaining lease term for the Company’s office operating lease as of June 30, 2024 was one
month. The lease was not renewed by the Company.
On
August 31, 2021, the Company completed the acquisition of its second acquired medical billing company, through Nobility Healthcare. Upon
completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The
lease was renewed in April 2023 with favorable terms and payments ranging from $7,436 to $8,877 thereafter, with a termination date in
March 2030. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related
to this location. The remaining term for the Company’s office operating lease was sixty-nine months as of June 30, 2024.
On
September 1, 2021, the Company completed the acquisition of Goody Tickets, LLC and TicketSmarter, LLC through TicketSmarter. Upon completion
of this acquisition, the Company became responsible for the operating lease for TicketSmarter’s office space. The lease terms include
monthly payments ranging from $7,211 to $7,364 thereafter, with a termination date of December 2022. The Company is responsible for property
taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of
the leased facilities on September 1, 2021. The Company currently rents this space on a month-to-month basis with intentions to relocate
upon the identification of suitable space.
On
January 1, 2022, the Company completed the acquisition of a private medical billing company, through its revenue cycle management segment.
Upon completion of this acquisition, the Company became responsible for the operating lease for the seller’s office space. The
lease terms include monthly payments ranging from $4,233 to $4,626, with a termination date of June 2025. The Company is responsible
for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took
possession of the leased facilities on January 1, 2022. The Company terminated this lease in January 2024 and reversed the right of use
asset and lease liability by $73,894.
Lease
expense related to the office space and copier operating leases were recorded on a straight-line basis over their respective lease terms.
Total lease expense under the operating leases was approximately $117,810 and $226,695 during the three and six months ended June 30,
2024.
The
weighted-average remaining lease term related to the Company’s lease liabilities as of June 30, 2023 was 4.3 years.
The
discount rate implicit within the Company’s operating leases was not generally determinable and therefore the Company determined
the discount rate based on its incremental borrowing rate on the information available at commencement date. As of commencement date,
the operating lease liabilities reflect a weighted average discount rate of 8%.
The
following sets forth the operating lease right of use assets and liabilities as of June 30, 2024:
SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES
Assets: | |
| | |
Operating lease right of use assets | |
$ | 869,166 | |
| |
| | |
Liabilities: | |
| | |
Operating lease obligations-current portion | |
$ | 223,629 | |
Operating lease obligations-less current portion | |
| 692,423 | |
Total operating lease obligations | |
$ | 916,052 | |
The
components of lease expense were as follows for the six months ended June 30, 2024:
SCHEDULE OF LEASE EXPENSE
| |
| | |
Selling, general and administrative expenses | |
$ | 226,695 | |
Following
are the minimum lease payments for each year and in total:
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS
Year ending December 31: | |
| |
2024 (July 1, to December 31, 2024) | |
$ | 146,105 | |
2025 | |
| 288,720 | |
2026 | |
| 293,300 | |
2027 | |
| 117,492 | |
Thereafter | |
| 235,020 | |
Total undiscounted minimum future lease payments | |
| 1,080,637 | |
Imputed interest | |
| (164,585 | ) |
Total operating lease liability | |
$ | 916,052 | |
NOTE
10. GOODWILL AND OTHER INTANGIBLE ASSETS
Intangible
assets consisted of the following at June 30, 2024 and December 31, 2023:
SCHEDULE OF INTANGIBLE ASSETS
| |
June 30, 2024 | | |
December 31, 2023 | |
| |
Gross value | | |
Accumulated amortization | | |
Net carrying value | | |
Gross value | | |
Accumulated amortization | | |
Net carrying value | |
Amortized intangible assets: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Licenses (video solutions segment) | |
$ | 151,652 | | |
$ | 21,270 | | |
$ | 130,382 | | |
$ | 225,545 | | |
$ | 89,887 | | |
$ | 135,658 | |
Patents and trademarks (video solutions segment) | |
| 483,521 | | |
| 332,462 | | |
| 151,059 | | |
| 483,521 | | |
| 266,403 | | |
| 217,118 | |
Sponsorship agreement network (entertainment segment) | |
| | |
| | |
| | |
| | |
| | |
| |
SEO content (entertainment segment) | |
| 600,000 | | |
| 425,000 | | |
| 175,000 | | |
| 600,000 | | |
| 350,000 | | |
| 250,000 | |
Personal seat licenses (entertainment segment) | |
| 117,339 | | |
| 11,081 | | |
| 106,258 | | |
| 180,081 | | |
| 14,004 | | |
| 166,077 | |
Software | |
| 23,653 | | |
| — | | |
| 23,653 | | |
| - | | |
| - | | |
| - | |
Website enhancements (entertainment segment) | |
| 25,630 | | |
| 4,014 | | |
| 21,616 | | |
| 13,500 | | |
| — | | |
| 13,500 | |
Client agreements (revenue cycle management segments) | |
| 999,034 | | |
| 276,719 | | |
| 722,315 | | |
| 999,034 | | |
| 226,768 | | |
| |